Therapeutics Advances
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Ophthalmol. Aug 12, 2013; 3(3): 20-31
Published online Aug 12, 2013. doi: 10.5318/wjo.v3.i3.20
Keratoconus therapeutics advances
Martha Jaimes, Arturo Ramirez-Miranda, Enrique O Graue-Hernández, Alejandro Navas
Martha Jaimes, Arturo Ramirez-Miranda, Enrique O Graue-Hernández, Alejandro Navas, Department of Cornea and Refractive Surgery, Institute of Ophthalmology “Conde de Valenciana”, 06800 Mexico City, Mexico
Author contributions: All the authors fulfill the Vancouver definition of authorship; Jaimes M and Navas A contributed to conception and design, drafting the article and final approved of the version to be published; Ramirez-Miranda A and Graue-Hernández EO contributed to acquisition of data, revising the article for important intellectual content and final approved of the version to be published.
Correspondence to: Alejandro Navas, MD, MSc, Department of Cornea and Refractive Surgery, Institute of Ophthalmology “Conde de Valenciana”, Chimalpopoca 14, Col Obrera, 06800 Mexico City, Mexico. dr.alejandro.navas@gmail.com
Telephone: +52-55-54421700 Fax: +52-55- 55789748
Received: June 29, 2013
Revised: August 10, 2013
Accepted: August 11, 2013
Published online: August 12, 2013
Processing time: 104 Days and 3.7 Hours
Core Tip

Core tip: There are several treatment options for the current management of keratoconus patients. These alternatives are increasing and better outcomes could be obtained. The purpose of this review is to summarize the therapeutics advances in keratoconus.